Odyssey Therapeutics, Inc 10-Q for FY2026 Q3
Odyssey Therapeutics, Inc. (ODTX)
10-Q
2026-11-04
For: 2026-09-30
View Original
Added on
November 04, 2026
About this 10-Q
Odyssey Therapeutics, Inc filed this 10-Q on November 4, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $99K a year earlier
- Net loss
- $53.06M
- compared with a net loss of $35.46M a year earlier
- Diluted EPS
- -$1.10
- compared with -$7.78 a year earlier